Millions of asthma patients who rely on blue salbutamol inhalers are being urged to contact their GP following a new warning from the National Institute for Health and Care Excellence (NICE). The guidance highlights potential risks associated with over-reliance on these rescue inhalers.
NICE advises that patients using blue inhalers three or more times a week may not have their condition adequately controlled. Such frequent use could indicate the need for a review of their asthma management plan, including possible adjustments to preventer medication.
The warning comes as part of a broader effort to improve asthma care and reduce the risk of severe attacks. Health officials emphasize that patients should not stop using their blue inhalers without consulting a healthcare professional.
Asthma UK has welcomed the guidance, stressing the importance of regular check-ups. A spokesperson noted that many patients could benefit from a review of their treatment to ensure optimal control of symptoms.
